Literature DB >> 28912600

The human microbiome: opportunity or hype?

Pedro M Valencia1, Magali Richard2, Jesse Brock3, Elsy Boglioli4.   

Abstract

Entities:  

Year:  2017        PMID： 28912600     DOI： 10.1038/nrd.2017.154

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

Review 1.  Microbiota: a novel regulator of pain.

Authors:  Manon Defaye; Sandie Gervason; Christophe Altier; Jean-Yves Berthon; Denis Ardid; Edith Filaire; Frédéric Antonio Carvalho
Journal:  J Neural Transm (Vienna)       Date:  2019-09-24       Impact factor: 3.575

Review 2.  Natural products in drug discovery: advances and opportunities.

Authors:  Atanas G Atanasov; Sergey B Zotchev; Verena M Dirsch; Claudiu T Supuran
Journal:  Nat Rev Drug Discov       Date:  2021-01-28       Impact factor: 112.288

Review 3.  Microbial metabolites: cause or consequence in gastrointestinal disease?

Authors:  Serge Alain Fobofou; Tor Savidge
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-03-10       Impact factor: 4.871

4.  Differences in the gut microbiome composition of Korean children and adult samples based on different DNA isolation kits.

Authors:  Changyoon Baek; Woo Jin Kim; JaeWoo Moon; Seo Yoon Moon; Wonsub Kim; Hae-Jin Hu; Junhong Min
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

5.  Bioactive Synthetic-Bioinformatic Natural Product Cyclic Peptides Inspired by Nonribosomal Peptide Synthetase Gene Clusters from the Human Microbiome.

Authors:  John Chu; Xavier Vila-Farres; Sean F Brady
Journal:  J Am Chem Soc       Date:  2019-09-27       Impact factor: 15.419
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.